)
PROCEPT BioRobotics (PRCT) investor relations material
PROCEPT BioRobotics Piper Sandler 37th Annual Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Inventory management and procedure growth
Inventory workdown was prioritized to right-size stock at sites, focusing on procedure volume rather than stocking orders as a business health indicator.
Adjustments were made after analysis showed excess inventory at many accounts, with guidance reflecting these changes.
Emphasis is on establishing PAR values and managing inventory to match true account utilization, aiming for 6–8 weeks of stock.
A new launch process was piloted, requiring centers to have screened cases ready, which improved utilization and referral cadence.
Dedicated launch teams were created to specialize in onboarding, freeing others to focus on ongoing training and procedure growth.
Commercial execution and strategic focus
Commercial execution improvements, including more efficient launches and a focus on same-store sales, are expected to drive growth.
The company is transitioning from a "new therapy" mindset to capturing a larger share of eligible patients and pulling more patients off the sidelines.
Patient-centric messaging will be prioritized, highlighting durable outcomes, low complication rates, and preserved sexual and bladder function.
Existing clinical evidence is strong, positioning the therapy in a "Goldilocks" zone between efficacy and safety.
Marketing efforts will focus on education through social media and referral networks rather than large-scale direct-to-consumer campaigns.
Capital sales, replacement cycle, and guidance
Capital sales remained strong despite increased scrutiny and longer closing cycles, with no loss of sales, only timing shifts.
The replacement cycle for older systems is expected to become meaningful in 2026, with a focus on upgrading to the HYDROS platform.
A cohesive replacement strategy is being developed, with future innovation centered on HYDROS and less focus on legacy systems.
Guidance for next year reflects business as usual, with upside potential from better commercial execution and replacement strategy.
Achieving the high end of guidance depends on faster implementation of initiatives and improved referral and launch processes.
Next PROCEPT BioRobotics earnings date
Next PROCEPT BioRobotics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)